Cargando…
Inhibition of Rho Kinase by Fasudil Ameliorates Cognition Impairment in APP/PS1 Transgenic Mice via Modulation of Gut Microbiota and Metabolites
Background: Fasudil, a Rho kinase inhibitor, exerts therapeutic effects in a mouse model of Alzheimer's disease (AD), a chronic neurodegenerative disease with progressive loss of memory. However, the mechanisms remain unclear. In addition, the gut microbiota and its metabolites have been implic...
Autores principales: | Yan, Yuqing, Gao, Ye, Fang, Qingli, Zhang, Nianping, Kumar, Gajendra, Yan, Hailong, Song, Lijuan, Li, Jiehui, Zhang, Yuna, Sun, Jingxian, Wang, Jiawei, Zhao, Linhu, Skaggs, Keith, Zhang, Han-Ting, Ma, Cun-Gen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551711/ https://www.ncbi.nlm.nih.gov/pubmed/34721000 http://dx.doi.org/10.3389/fnagi.2021.755164 |
Ejemplares similares
-
Transcriptome analysis of fasudil treatment in the APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer’s disease
por: Yan, Hailong, et al.
Publicado: (2022) -
Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases
por: Wang, Qing, et al.
Publicado: (2022) -
The role of Rho/Rho-kinase pathway and the neuroprotective effects of fasudil in chronic cerebral ischemia
por: Yan, Ya-yun, et al.
Publicado: (2015) -
Fasudil in Combination With Bone Marrow Stromal Cells (BMSCs) Attenuates Alzheimer’s Disease-Related Changes Through the Regulation of the Peripheral Immune System
por: Yu, Jiezhong, et al.
Publicado: (2018) -
Effect of Fasudil on remyelination following cuprizone‐induced demyelination
por: Wang, Jing, et al.
Publicado: (2019)